Updated Jul 16, 2026
Kunkel Lori Anne has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $850K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-08 | ELVN | Enliven Therapeutics, Inc. | S — Open-market sale | 5.9K | $50.84 | $299K |
| 2026-07-08 | ELVN | Enliven Therapeutics, Inc. | S — Open-market sale | 4.1K | $49.98 | $205K |
| 2026-06-09 | ELVN | Enliven Therapeutics, Inc. | S — Open-market sale | 354 | $35.82 | $13K |
| 2026-06-09 | ELVN | Enliven Therapeutics, Inc. | S — Open-market sale | 1.9K | $35.36 | $66K |
| 2026-06-09 | ELVN | Enliven Therapeutics, Inc. | S — Open-market sale | 7.8K | $34.28 | $267K |
| 2025-12-05 | ORIC | Oric Pharmaceuticals, Inc. | M — Option exercise | 5.5K | $3.75 | $21K |
Kunkel Lori Anne is a corporate insider — currently tracked as Insider of Enliven Therapeutics, Inc. (ELVN). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($850K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kunkel Lori Anne profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.